Table 4. Impact of hyperoxemia on secondary outcomes.
Outcomes | Percentage of time spent with hyperoxemia >43% | P value | |
---|---|---|---|
Yes (n=47) | No (n=46) | ||
Duration of mechanical ventilation, days | 25 [16, 46] | 22 [11, 46] | 0.412 |
Mechanical-ventilation free days | 3 [0, 10] | 5 [0, 10] | 0.942 |
SOFA score at VAP occurrence | 5 [4, 10] | 7 [4, 10] | 0.269 |
Length of ICU stay, days | 30 [22, 53] | 29 [17, 52] | 0.410 |
Data are presented median [interquartile range]. SOFA, sequential organ failure assessment; VAP, ventilator-associated pneumonia; ICU, intensive care unit.